Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism

Recent study suggests that auranofin (AF), a US Food and Drug Administration (FDA)-approved drug for treatment of rheumatoid arthritis, has selective anticancer activity in various experimental models. Its clinical applications in cancer treatment, however, have been hampered due in part to its rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yi, Chen, Ping, Zhang, Yanyu, Lu, Wenhua, Ding, Wenwen, Luo, Yao, Wen, Shijun, Xu, Ruihua, Liu, Panpan, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678510/
https://www.ncbi.nlm.nih.gov/pubmed/31277230
http://dx.doi.org/10.3390/cancers11070931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678510/
https://www.ncbi.nlm.nih.gov/pubmed/31277230
http://dx.doi.org/10.3390/cancers11070931

Ejemplares similares